
.
marketwatch: "new migraine drugs have promise -- and a ,500 price tag.".
the situation has become so bad that a cross-party committee of politicians called it a.
the patient was treated at the royal devon & exeter nhs foundation trust..
.of the life claims declined, 0.85 per cent were due to mis-representation and 0.16 per cent due to the definition of terminal illness not being met. .: "targeted cgrp small molecule antagonists for acute migraine therapy.".
"the treatment of our family and the behaviour of the western trust has been disgraceful, they should be ashamed of themselves.